Medical Aspects of Biological WarfareZygmunt F. Dembek NOTE: NO FURTHER DISCOUNT FOR THIS PRINT PRODUCT-- OVERSTOCK SALE -- Significantly reduced list price while supplies last Reflecting the critical threat posed by biological warfare and terrorism in a post 9-11 world, Medical Aspects of Biological Warfare (an update of Medical Aspects of Chemical and Biological Warfare published in 1997) addresses the weaponization of biological agents, categorizing potential agents as food, waterborne, or agricultural agents or toxins, and discusses their respective epidemiology. Recent advances in biomedical knowledge are presented that include descriptions of individual agents and the illnesses induced. Authors discuss biotoxins and explain methods for early identification for anthrax, plague, smallpox, alphaviruses, and staphylococcal enterotoxins. Case studies and research on successful management practices, treatments, and antidotes are also included. Related products: Physician References & Medical Handbooks resources collection can be found here: https: //bookstore.gpo.gov/catalog/health-benefits/physician-references-medical-handbooks Airborne Hazards Related to Deployment --Print Paperback format -can be found here: https: //bookstore.gpo.gov/products/sku/008-023-00154-5 2016 Emergency Response Guidebook is available here: https: //bookstore.gpo.gov/products/sku/050-000-00597-6 Other products produced by The Borden Institute can be found here: https: //bookstore.gpo.gov/agency/1140 |
Other editions - View all
Common terms and phrases
1425 Porter Street acute aerosol animals antibiotic antibody antigen Army Medical Research assay Bacillus anthracis bacterial biological agents biological warfare biological weapons biosafety bioterrorism botulinum toxin botulism Brucella brucellosis Burkholderia pseudomallei burnetii cause cells Centers for Disease chemical ciprofloxacin Clin Microbiol clinical contaminated Control and Prevention Coxiella burnetii detection Detrick developed diagnosis Disease Control dose doxycycline drug Ebola virus Emerg Infect epidemic epidemiological exposure F tularensis Fort Detrick Francisella tularensis gene glanders hemorrhagic fever human identified Infect Immun Infectious Diseases Institute of Infectious isolated lethal mallei Maryland Medical Research Institute melioidosis mice military monkeys mycotoxins occurred organism outbreak pathogens patients personnel pestis plague postexposure potential prophylaxis protection protein public health Q fever reported respiratory response ribavirin ricin risk safety serotype specific strains studies symptoms syndrome T-2 toxin testing therapy threat tion tissue titers toxic treatment trichothecene tularemia United vaccinia viral virulence viruses